Frederick, MD, United States of America

Ruigong Wang



 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Ruigong Wang: A Pioneer in Complement Research

Introduction

Ruigong Wang, based in Frederick, MD, is an accomplished inventor known for his significant contributions to the field of immunotherapy. With a remarkable portfolio of five patents, his work focuses primarily on enhancing our understanding and manipulation of the complement system, which plays a crucial role in the immune response.

Latest Patents

His most recent patents include innovative polypeptides that comprise complement factor B analogs. These inventions provide various complement factor B analogs that feature mutations of free cysteine amino acids. The related methods, nucleic acids, and vectors developed from these analogs hold potential for modulating the complement pathway. This technology is particularly valuable for the study and treatment of various conditions or diseases associated with complement pathways, demonstrating his dedication to advancing medical research and therapeutic development.

Career Highlights

Ruigong Wang’s career is marked by his affiliation with Wellstat Immunotherapeutics, LLC, where he has been involved in pioneering research and development initiatives. His role at Wellstat has allowed him to merge theoretical research with practical applications, highlighting the importance of innovation in therapeutic strategies.

Collaborations

Throughout his career, Ruigong has collaborated with notable peers, including ChangHung Chen and Michael Kaleko. These partnerships underscore the collaborative nature of scientific research and innovation, enabling the cross-pollination of ideas that can lead to breakthroughs in the field of immunotherapy and beyond.

Conclusion

Ruigong Wang stands out as a visionary inventor whose patented innovations contribute to our understanding of the immune system. His work not only demonstrates the potential of complement factor B analogs in therapeutic applications but also highlights the importance of collaborative efforts in advancing scientific technologies. As research in immunotherapy continues to evolve, Wang's contributions will undoubtedly pave the way for future advancements in this critical area of study.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…